Please provide your email address to receive an email when new articles are posted on . This study reports results from a prospective, randomized, double-blind trial. Use of IV tranexamic acid did not ...
The use of tranexamic acid (TXA) in patients undergoing oncology and other major noncardiac surgeries reduces the administration of red blood cell (RBC) transfusions across patient and surgical ...
Tranexamic acid (TXA) use is set to widen in England and Wales under new draft guidance from the National Institute for Health and Care Excellence (NICE). NICE recommends offering TXA before any ...
ORLANDO -- A hospital policy to increase the use of perioperative tranexamic acid (TXA) reduced blood transfusions during major noncardiac surgeries with no apparent impact on clotting events, a ...
Please provide your email address to receive an email when new articles are posted on . Tranexamic acid lowered the need for transfusions for patients undergoing non-cardiac surgeries compared with ...
Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically rather than intravenously did not meet its primary endpoint of reducing seizures and was stopped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results